国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Staphylococcus haemolyticus tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP680276SBAH
CSB-EP680276SBAH
CSB-BP680276SBAH
CSB-MP680276SBAH
CSB-EP680276SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP680277SBAH
CSB-EP680277SBAH
CSB-BP680277SBAH
CSB-MP680277SBAH
CSB-EP680277SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP680278SBAH
CSB-EP680278SBAH
CSB-BP680278SBAH
CSB-MP680278SBAH
CSB-EP680278SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus GTPase obg (obg) CSB-YP680279SBAH
CSB-EP680279SBAH
CSB-BP680279SBAH
CSB-MP680279SBAH
CSB-EP680279SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Glutamate-1-semialdehyde 2,1-aminomutase 2 (hemL2) CSB-YP680280SBAH
CSB-EP680280SBAH
CSB-BP680280SBAH
CSB-MP680280SBAH
CSB-EP680280SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 50S ribosomal protein L35 (rpmI) CSB-YP680281SBAH
CSB-EP680281SBAH
CSB-BP680281SBAH
CSB-MP680281SBAH
CSB-EP680281SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP680282SBAH
CSB-EP680282SBAH
CSB-BP680282SBAH
CSB-MP680282SBAH
CSB-EP680282SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Acetate kinase (ackA) CSB-YP680283SBAH
CSB-EP680283SBAH
CSB-BP680283SBAH
CSB-MP680283SBAH
CSB-EP680283SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Formate--tetrahydrofolate ligase (fhs), partial CSB-YP680284SBAH
CSB-EP680284SBAH
CSB-BP680284SBAH
CSB-MP680284SBAH
CSB-EP680284SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Putative dipeptidase SH1171 (SH1171) CSB-YP680285SBAH
CSB-EP680285SBAH
CSB-BP680285SBAH
CSB-MP680285SBAH
CSB-EP680285SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus S-adenosylmethionine synthase (metK) CSB-YP680286SBAH
CSB-EP680286SBAH
CSB-BP680286SBAH
CSB-MP680286SBAH
CSB-EP680286SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus UPF0754 membrane protein SH1116 (SH1116), partial CSB-YP680287SBAH1
CSB-EP680287SBAH1
CSB-BP680287SBAH1
CSB-MP680287SBAH1
CSB-EP680287SBAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus UPF0374 protein SH1094 (SH1094) CSB-YP680288SBAH
CSB-EP680288SBAH
CSB-BP680288SBAH
CSB-MP680288SBAH
CSB-EP680288SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Response regulator protein vraR (vraR) CSB-YP680289SBAH
CSB-EP680289SBAH
CSB-BP680289SBAH
CSB-MP680289SBAH
CSB-EP680289SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Diacylglycerol kinase (dagK) CSB-YP680290SBAH
CSB-EP680290SBAH
CSB-BP680290SBAH
CSB-MP680290SBAH
CSB-EP680290SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus DNA ligase (ligA), partial CSB-YP680291SBAH
CSB-EP680291SBAH
CSB-BP680291SBAH
CSB-MP680291SBAH
CSB-EP680291SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 60 kDa chaperonin (groL), partial CSB-YP680292SBAH
CSB-EP680292SBAH
CSB-BP680292SBAH
CSB-MP680292SBAH
CSB-EP680292SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Dihydroxy-acid dehydratase (ilvD), partial CSB-YP680293SBAH
CSB-EP680293SBAH
CSB-BP680293SBAH
CSB-MP680293SBAH
CSB-EP680293SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus L-threonine dehydratase biosynthetic IlvA (ilvA) CSB-YP680294SBAH
CSB-EP680294SBAH
CSB-BP680294SBAH
CSB-MP680294SBAH
CSB-EP680294SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus D-alanine--D-alanine ligase (ddl) CSB-YP680295SBAH
CSB-EP680295SBAH
CSB-BP680295SBAH
CSB-MP680295SBAH
CSB-EP680295SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>